Stephen Liu MD (He/Him)
Thoracic Cancer
Associate Professor, Georgetown University School of Medicine
Join to View Full Profile
3800 Reservoir Rd NWLombardi Comprehensive Cancer ClinicWashington, DC 20007
Phone+1 202-444-2223
Fax+1 202-444-7009
Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen V. Liu, MD, is an Associate Professor of Medicine, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC, USA. He is also the host for the official IASLC podcast, Lung Cancer Considered.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2009 - 2010- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2008 - 2009
University of Pennsylvania Health SystemResidency, Internal Medicine, 2005 - 2008
University of Maryland School of MedicineClass of 2005
Certifications & Licensure
DC State Medical License 2013 - 2026
MD State Medical License 2013 - 2026
CA State Medical License 2008 - 2013
PA State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor Start of enrollment: 2016 May 11
- A Study of EP0031 in Patients With Advanced RET-altered Malignancies Start of enrollment: 2022 Sep 30
Roles: Contact
- A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) Start of enrollment: 2022 Jan 04
Publications & Presentations
PubMed
- Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials.David E Gerber, Claire R Wynters, Tanushree Prasad, Ronny K Schnel, Song Zhang
Clinical Cancer Research. 2025-03-17 - Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small ce...Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, Stephen V Liu, Barbara Melosky
Lung Cancer. 2025-03-01 - Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer.Luis Paz-Ares, Brinda Gupta, Javier Baena, Stephen V Liu
Clinical Lung Cancer. 2025-03-01
Press Mentions
Zenocutuzumab Approved to Treat Lung and Pancreatic Cancers with Rare Genetic ChangeMarch 26th, 2025- Amid Funding Concerns, Promising Lung Cancer Vaccines Could Be Available in Next Few YearsMarch 11th, 2025
- Stephen Liu, MD, Shares Insights on the eNRGy TrialFebruary 20th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
